CRC Incidence Continues to Decrease Among Adults

Share this content:
CRC Incidence Continues to Decrease Among Adults
CRC Incidence Continues to Decrease Among Adults

(HealthDay News) — Incidence rates for colorectal cancer (CRC) declined by approximately 3% per year from 2001 to 2010 in the United States, with the largest drops occurring in adults aged 65 and older, according to research published in the March/April issue of CA: A Cancer Journal for Clinicians.

Rebecca Siegel, MPH, of the American Cancer Society in Atlanta, and colleagues compiled an overview of CRC statistics, including incidence data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program and the North American Association of Central Cancer Registries, as well as mortality data from the National Center for Health Statistics.

RELATED: Screening Cut Colorectal Cancer Deaths

The researchers found that, from 2001 to 2010, incidence rates for CRC decreased by approximately 3% per year; the largest drops occurred in adults aged 65 years and older, while rates increased among adults aged younger than 50 years.

More than one-third of all CRC deaths (29% in men and 43% in women) will occur in individuals aged 80 years or older. The incidence and death rates for CRC are highest in blacks and lowest in Asians/Pacific Islanders.

RELATED: Gastrointestinal Cancers Resource Center

"Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations," the researchers wrote.


  1. Siegel R, DeSantis C, Jemal A, et al. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):104-117.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs